This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VaxGen Down on Filing Delay

VaxGen (VXGN) shares fell early Tuesday after the company said it had asked the Securities and Exchange Commission for a five-day extension to file its earnings statement for the three months ended March 31.

The Brisbane, Calif.-based biotechnology company had planned to release and discuss its first-quarter financial report Tuesday.

According to Thomson First Call, VaxGen was expected to produce a first- quarter loss of 45 cents. Only one analyst follows the company, according to the Thomson First Call survey.

The company said it will set a new release date and new conference call for investors and analysts after it has determined a new filing date for the 10-Q statement.

VaxGen said it needed more time to complete the preparation and review of materials necessary for filing its 10-Q statement and for its new independent auditor, which had been hired April 9, to review the documents. VaxGen is developing vaccines for anthrax and smallpox.

In premarket trading, the company's stock was down 36 cents, or 2.5%, to $14.36.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
AAPL $118.40 -2.40%
FB $94.13 0.13%
GOOG $631.28 0.91%
TSLA $259.66 -2.40%
YHOO $36.69 0.06%


Chart of I:DJI
DOW 17,598.20 -91.66 -0.52%
S&P 500 2,098.04 -5.80 -0.28%
NASDAQ 5,115.3820 -12.8990 -0.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs